» Articles » PMID: 9712085

Analysis of Type 1 and Type 2 T Cells in Synovial Fluid and Peripheral Blood of Patients with Rheumatoid Arthritis

Overview
Journal J Rheumatol
Specialty Rheumatology
Date 1998 Aug 26
PMID 9712085
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: It has been reported that CD4+ helper T cells play an important role in the pathogenesis of rheumatoid arthritis (RA). We evaluated the presence of intracellular cytokines interleukin 4 (IL-4) and interferon-gamma (IFN-gamma) produced by CD4+ and CD8+ T cells in the synovial fluid and peripheral blood of patients with RA at the single cell level.

Methods: We used 3 color flow cytometric analysis. Synovial fluid mononuclear cells (SFMC) and peripheral blood mononuclear cells (PBMC) were stimulated with phorbol myristate acetate (PMA) and calcium ionophore. The stimulated SFMC and PBMC were triple stained with conjugated mononuclear antibodies (Mab) against cytokines and surface antigens after fixation and permeabilization with a saponine buffer solution. The cells were analyzed for intracellular cytokines (IFN-gamma, IL-4) and surface antigens (CD3, CD4, CD8) using a flow cytometer.

Results: The CD4/CD8 ratio was significantly lower in SFMC than in PBMC. The positive rates of IFN-gamma producing cells among CD4+ T cells were significantly higher than those of IL-4 producing cells in both the SFMC and the PBMC of patients with active RA. In the SF of these patients, we also found CD8+ T cells that produce IL-4 alone, or both IL-4 and IFN-gamma.

Conclusion: In the SF of patients with RA, CD4+ type 1 T cells, which may infiltrate into the synovium and cause pathogenic immune responses in the tissue, are predominant. We believe this cell type also induces migration and activation of CD8+ type 2 T cells into the active site of inflammation, which appears to downregulate the activity of CD4+ type 1 T cells, modulating the excess immune response.

Citing Articles

Conventional Tregs in treatment-naïve rheumatoid arthritis are deficient in suppressive function with an increase in percentage of CXCR3 and CCR6 expressing Tregs.

Kommoju V, Mariaselvam C, Bulusu S, Ganapathy C, Narasimhan P, Thabah M Immunol Res. 2023; 72(3):396-408.

PMID: 38151700 DOI: 10.1007/s12026-023-09444-7.


Dopamine D2 receptor on CD4 T cells is protective against inflammatory responses and signs in a mouse model of rheumatoid arthritis.

Wang X, Cai H, Deng Q, Chang Y, Peng Y, Qiu Y Arthritis Res Ther. 2023; 25(1):87.

PMID: 37237413 PMC: 10214709. DOI: 10.1186/s13075-023-03071-1.


Immunomodulatory Effects of Curcumin in Rheumatoid Arthritis: Evidence from Molecular Mechanisms to Clinical Outcomes.

Haftcheshmeh S, Khosrojerdi A, Aliabadi A, Lotfi S, Mohammadi A, Momtazi-Borojeni A Rev Physiol Biochem Pharmacol. 2021; 179:1-29.

PMID: 33404796 DOI: 10.1007/112_2020_54.


Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson's Disease.

Kelly R, Joers V, Tansey M, McKernan D, Dowd E Molecules. 2020; 25(3).

PMID: 31973235 PMC: 7037317. DOI: 10.3390/molecules25030453.


Norepinephrine Inhibits Th17 Cells via β2-Adrenergic Receptor (β2-AR) Signaling in a Mouse Model of Rheumatoid Arthritis.

Liu Y, Rui X, Shi H, Qiu Y, Peng Y Med Sci Monit. 2018; 24:1196-1204.

PMID: 29485127 PMC: 5839072. DOI: 10.12659/msm.906184.